1 Improvement of dependency at the end of treatment |
11 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
1.1 Barthel Index |
9 |
616 |
Mean Difference (IV, Random, 95% CI) |
9.19 [4.34, 14.05] |
1.2 Modified Barthel Index |
1 |
60 |
Mean Difference (IV, Random, 95% CI) |
3.44 [0.30, 6.58] |
1.3 ADL |
1 |
62 |
Mean Difference (IV, Random, 95% CI) |
7.80 [6.04, 9.56] |
2 Improvement of dependency at the end of follow‐up |
2 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
2.1 Barthel index |
1 |
147 |
Mean Difference (IV, Random, 95% CI) |
7.49 [1.79, 13.19] |
2.2 ADL |
1 |
71 |
Mean Difference (IV, Random, 95% CI) |
3.83 [2.67, 4.99] |
3 Improvement of global neurological deficit at the end of treatment |
6 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
3.1 Modified Edinburgh and Scandinavian Stroke Scale |
4 |
240 |
Mean Difference (IV, Random, 95% CI) |
‐2.39 [‐3.34, ‐1.43] |
3.2 Neurological function deficit scale |
2 |
123 |
Mean Difference (IV, Random, 95% CI) |
‐1.02 [‐5.80, 3.76] |
4 Improvement of global neurological deficit at the end of follow‐up |
2 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
4.1 Neurological function deficit scale |
1 |
71 |
Mean Difference (IV, Random, 95% CI) |
‐6.15 [‐7.09, ‐5.21] |
4.2 NIHSS |
1 |
147 |
Mean Difference (IV, Random, 95% CI) |
‐0.83 [‐1.94, 0.28] |
5 Improvement of global neurological deficit at the end of treatment |
7 |
543 |
Odds Ratio (M‐H, Random, 95% CI) |
3.89 [1.78, 8.49] |
6 Improvement of motor function at the end of treatment |
5 |
|
Mean Difference (IV, Fixed, 95% CI) |
Subtotals only |
6.1 Upper and lower extremities motor function(Fugl‐Meyer Assessment) |
4 |
245 |
Mean Difference (IV, Fixed, 95% CI) |
6.16 [4.20, 8.11] |
6.2 General motor function (Motor assessment scale) |
1 |
60 |
Mean Difference (IV, Fixed, 95% CI) |
4.53 [2.99, 6.07] |
7 Improvment of general motor function at the end of follow‐up (Fugl‐Meyer Assessment) |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
Subtotals only |
8 Improvement of motor function at the end of treatment (Fugl‐Meyer Assessment) |
2 |
125 |
Odds Ratio (M‐H, Random, 95% CI) |
2.41 [0.98, 5.96] |
9 Improvement of cognitive function at the end of treatment |
5 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
9.1 MMSE |
5 |
278 |
Mean Difference (IV, Random, 95% CI) |
2.54 [0.03, 5.05] |
9.2 MoCA |
2 |
120 |
Mean Difference (IV, Random, 95% CI) |
1.34 [0.76, 1.92] |
9.3 HDS‐R |
1 |
46 |
Mean Difference (IV, Random, 95% CI) |
1.26 [0.29, 2.23] |
10 Improvment of cognitive function at the end of follow‐up (MMSE) |
1 |
71 |
Mean Difference (IV, Fixed, 95% CI) |
3.47 [2.43, 4.51] |
11 Improvement of cognitive function at the end of treatment |
3 |
|
Odds Ratio (M‐H, Random, 95% CI) |
Subtotals only |
11.1 MMSE |
3 |
166 |
Odds Ratio (M‐H, Random, 95% CI) |
3.82 [1.89, 7.72] |
11.2 HDS‐R |
1 |
46 |
Odds Ratio (M‐H, Random, 95% CI) |
4.02 [1.12, 14.46] |
12 Improvement of depression at the end of treatment |
6 |
|
Mean Difference (IV, Fixed, 95% CI) |
Subtotals only |
12.1 HAMD |
6 |
552 |
Mean Difference (IV, Fixed, 95% CI) |
‐2.58 [‐3.28, ‐1.87] |
12.2 Symptoms of TCM depression scale |
1 |
60 |
Mean Difference (IV, Fixed, 95% CI) |
‐1.57 [‐2.96, ‐0.18] |
13 Improvement of depression at the end of treatment (HAMD) |
4 |
342 |
Odds Ratio (M‐H, Random, 95% CI) |
2.03 [1.10, 3.72] |
14 Improvement of swallowing function at the end of treatment (Water drinking test) |
2 |
200 |
Mean Difference (IV, Random, 95% CI) |
‐1.11 [‐2.08, ‐0.14] |
15 Improvement of swallowing function at the end of treatment (Water drinking test) |
1 |
60 |
Odds Ratio (M‐H, Random, 95% CI) |
95.29 [10.93, 830.86] |
16 Improvement of pain at the end of treatment (Visual Analogue Scale) |
2 |
118 |
Mean Difference (IV, Fixed, 95% CI) |
‐2.88 [‐3.68, ‐2.09] |
17 Improvement of sleep quality at the end of treatment (Rhone Planck Sleepiness Scale) |
1 |
60 |
Mean Difference (IV, Fixed, 95% CI) |
‐1.09 [‐2.37, 0.19] |
18 Improvement of spasticity at the end of treatment (Modified Ashworth Spasticity Rating Scale) |
1 |
60 |
Mean Difference (IV, Fixed, 95% CI) |
‐0.4 [‐0.64, ‐0.16] |
19 Improvement of quality of life at the end of treatment (MOS SF‐36) |
1 |
71 |
Mean Difference (IV, Fixed, 95% CI) |
2.73 [‐0.54, 6.00] |